Process for preparation of beta-lactam derivatives

Abstract: The invention provides a process for preparing a β-lactam derivative represented by the following formula (2) and/or the corresponding enol tautomer (which may be produced depending on its structure), the process comprising oxidizing an alkenyl-substituted β-lactam derivative represented by the following formula (1) in the presence of a ruthenium catalyst or a rhenium catalyst using a periodic acid or a salt thereof: wherein R¹ is a hydrogen atom, a C₁₋₄ alkyl group or a C₁₋₄ haloakyl group, R² is a hydrogen atom, a C₁₋₄ alkyl group or a phenyl group which may have a substituent, A is a group represented by the formula a group represented by the formula or a group represented by the formula wherein R³ is an amino group or a protected amino group, R⁴ is a hydrogen atom or a group for protecting a carboxylic acid, one of R⁵ and R⁶ is a hydrogen atom and the other is either a hydroxyl group or a protected hydroxyl group, or R⁵ and R⁶, when taken together, represent an oxo group or a group represented by the formula wherein R⁷ is a hydrogen atom, a C₁₋₄ alkyl group, a phenyl group which may have a substituent, or a group -COOR⁸ wherein R⁸ is a hydrogen atom or a C₁₋₄ alkyl group, X is a hydrogen atom, a halogen atom, a hydroxyl group or a protected hydroxyl group, and Y is a group of the formula -SO₂Ar or -SAr wherein Ar is an aryl group which may have a substituent or a nitrogen-containing aromatic heterocyclic group which may have a substituent; and wherein R¹ and A are as defined above.

Description: The present invention relates to a novel process for preparing a β-lactam derivative. A process using ozone is widely known for preparing a β-lactam derivative represented by the following formula (2) and/or the corresponding enol tautomer (which may be produced depending on its structure) from an alkenyl-substituted β-lactam derivative represented by the following formula (1): wherein R¹ is a hydrogen atom, a C₁₋₄ alkyl group or a C₁₋₄ haloalkyl group, R² is a hydrogen atom, a C₁₋₄ alkyl group or a phenyl group which may have a substituent, A is a group represented by the formula a group represented by the formula or a group represented by the formula wherein R³ is an amino group or a protected amino group, R⁴ is a hydrogen atom or a group for protecting a carboxylic acid, one of R⁵ and R⁶ is a hydrogen atom and the other is either a hydroxyl group or a protected hydroxyl group, or R⁵ and R⁶, when taken together, represent an oxo group or a group represented by the formula wherein R⁷ is a hydrogen atom, a C₁₋₄ alkyl group, a phenyl group which may have a substituent, or a group -COOR⁸ wherein R⁸ is a hydrogen atom or a C₁₋₄ alkyl group, X is a hydrogen atom, a halogen atom, a hydroxyl group or a protected hydroxyl group, and Y is a group of the formula -SO₂Ar or -SAr wherein Ar is an aryl group which may have a substituent or a nitrogen-containing aromatic heterocyclic group which may have a substituent; wherein R¹ and A are as defined above (see, e.g. JP-A-129590/1975 and 98265/1976 and also US-A-4,160,085 and EP-A-215 435 for similar reactions). However, the process using ozone has the disadvantages of requiring special equipment and unavoidably producing a highly explosive ozonide as an intermediate during the ozone-oxidizing reaction, consequently involving a dangerous procedure. Another problem is that the ozone-oxidizing reaction must be conducted using ozone in the form of a dilute solution at an extremely low temperature, making it difficult to carry out the process on an industrial basis. As described hereinbefore, the conventional processes for preparing the β-lactam derivative of the formula (2) from the alkenyl-substituted β-lactam derivative of the formula (1) by the oxidation of ozone are difficult to industrially practice and have various drawbacks to be overcome. It is an object of the present invention to provide a novel process for preparing the derivative of the formula (2) and/or the corresponding enol tautomer with a high purity in a high yield from the derivative of the formula (1), the process being free of the drawbacks of the foregoing conventional processes, safe and convenient to perform and industrially fully feasible. We conducted extensive research to achieve the foregoing object and found that when a specific oxidizing agent is used, the reaction for oxidizing the derivative of the formula (1) is permitted to proceed smoothly and the foregoing object is completely fulfilled. The present invention has been accomplished based on this novel finding. According to the present invention, there is provided a process for preparing a β-lactam derivative represented by the following formula (2) and/or the corresponding enol tautomer (which may be produced depending on its structure), the process comprising oxidizing an alkenyl-substituted β-lactam derivative represented by the following formula (1) in an organic solvent or a water-containing organic solvent or in a two-phase system if the organic solvent is immiscible with water in the presence of a ruthenium catalyst or a rhenium catalyst using a periodic acid or a salt thereof: wherein R¹ is a hydrogen atom, a C₁₋₄ alkyl group or a C₁₋₄ haloalkyl group,R² is a hydrogen atom, a C₁₋₄ alkyl group or a phenyl group which may have a substituent, A is a group represented by the formula a group represented by the formula or a group represented by the formula wherein R³ is an amino group or a protected amino group, R⁴ is a hydrogen atom or a group for protecting a carboxylic acid, one of R⁵ and R⁶ is a hydrogen atom and the other is either a hydroxyl group or a protected hydroxyl group, or R⁵ and R⁶, when taken together, represent an oxo group or a group represented by the formula wherein R⁷ is a hydrogen atom, a C₁₋₄ alkyl group, a phenyl group which may have a substituent, or a group -COOR⁸ wherein R⁸ is a hydrogen atom or a C₁₋₄ alkyl group, X is a hydrogen atom, a halogen atom, a hydroxyl group or a protected hydroxyl group, and Y is a group of the formula -SO₂Ar or -SAr wherein Ar is an aryl group which may have a substituent or a nitrogen-containing aromatic heterocyclic group which may have a substituent; and wherein R¹ and A are as defined above. Sodium metaperiodate and ruthenium tetroxide have been recommended in EP-A-136 788 for the oxidation of a sulfide or sulfinyl group of a penicillin or cephalosporine compound. According to the invention, the derivative of the formula (2) and/or the corresponding enol tautomer can be safely and industrially prepared with a high purity in a high yield by means of simple procedure from the derivative of the formula (1) using a ruthenium catalyst or a rhenium catalyst and a periodic acid or a salt thereof in combination. Typical examples of the C₁₋₄ alkyl group are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, Specific examples of the C₁₋₄ haloalkyl group are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl and the like which contain 1 to 3 halogen atoms such as chlorine, bromine, iodine. Examples of the substituent which the phenyl group may have are fluorine atom, chlorine atom, bromine atom, iodine atom and like halogen atoms; methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl and like C₁₋₄ alkyl groups; methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, tert-butoxy and like C₁₋₄ alkoxy groups; nitro group; cyano group; amino, methylamino, dimethylamino, ethylamino, diethylamino and like amino groups which may have a C₁₋₄ alkyl group as a substituent; hydroxyl group; acetoxy group; mercapto group; methylthio group; acetylthio group; acetyl group;. A suitable combination of 1 to 5 of these substituents which may be the same or different can be present as the substituent for the phenyl group. Examples of the protected amino group include the groups described in Theodora W. Greene, "Protective Group in Organic Synthesis" (hereinafter simply referred to as "literature"), Chapter 7, pp 218-287, and phenoxyacetamide, p-methylphenoxyacetamide, p-methoxyphenoxyacetamide, p-chlorophenoxyacetamide, p-bromophenoxyacetamide, phenylacetamide, p-methylphenylacetamide, p-methoxyphenylacetamide, p-chlorophenylacetamide, p-bromophenylacetamide, phenylmonochloroacetamide, phenyldichloroacetamide, phenylhydroxyacetamide, phenylacetoxyacetamide, α-oxophenylacetamide, thienylacetamide, benzamide, p-methylbenzamide, p-methoxybenzamide, p-chlorobenzamide, p-bromobenzamide, phenylglycylamide, phenylglycylamide with the amino group fully protected, p-hydroxyphenylglycylamide, p-hydroxyphenylglycylamide with one or both of amino group and hydroxyl group fully protected. Examples of protective groups for the amino group of phenylglycylamide and p-hydroxyphenylglycylamide include the groups stated in the foregoing literature, Chapter 7, pp 218-287. Examples of protective groups for the hydroxyl group of p-hydroxyphenylglycylamide include those described in the foregoing literature, Chapter 2, pp 10-72. Examples of protective groups for the carboxylic acid include the groups exemplified in said literature, Chapter 5, pp 152-192, and benzyl group, p-methoxybenzyl group, p-nitrobenzyl group, diphenylmethyl group, trichloroethyl group, tert-butyl group. Examples of protective groups for the protected hydroxyl group are the groups set forth in said literature, Chaper 2, pp 10-72, and methyl group, ethyl group, isopropyl group, tert-butyl group, benzyl group, p-methylbenzyl group, p-methoxybenzyl group, diphenylmethyl group, trimethylsilyl group, tert-butyldimethylsilyl group, triethylsilyl group, phenyldimethylsilyl group, acetyl group. Halogen atoms include fluorine atom, chlorine atom, bromine atom, iodine atom,. Typical examples of the aryl group Ar which may have a substituent are unsubstituted aryl groups such as phenyl group, naphthyl group, substituted aryl groups having one of the substituents exemplified below, or two or more thereof which are different or the same (e.g. 5 or less for phenyl groups, or 7 or less for naphthyl groups). Specific examples of the above substituents include fluorine atom, chlorine atom, bromine atom, iodine atom and like halogen atoms; methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl and like C₁₋₄ alkyl groups; methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, tert-butoxy and like C₁₋₄ alkoxy groups; methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, tert-butylthio and like C₁₋₄ alkylthio groups; amino, methylamino, dimethylamino, ethylamino, diethylamino and like amino groups which may have 1 to 2 C₁₋₄ alkyl groups as the substituent; hydroxyl group; nitro group; cyano group; phenyl group; acyloxy group represented by the formula -OCOR⁹ wherein R⁹ is phenyl group, tolyl group or C₁₋₄ alkyl group; acyl group represented by the formula -COR⁹ wherein R⁹ is as defined above). Specific examples of the nitrogen-containing aromatic heterocyclic group Ar which may have a substituent are unsubstituted nitrogen-containing aromatic heterocyclic groups of the following formulas and substituted nitrogen-containing aromatic heterocyclic groups having one or more of substituents which are the same as those in said substituted aryl groups. It is essential in the invention to oxidize the alkenyl-substituted β-lactam derivative of the formula (1) with a periodic acid or a salt thereof in the presence of a ruthenium catalyst or a rhenium catalyst. The ruthenium catalyst for use in the invention can be any of conventional ruthenium compounds in the form of an oxide, halide, complex salt. Examples of useful ruthenium compounds are Ru(CO)₅, Ru(CO)₉, Ru₃(CO)₁₂, Ru(NO)₅, Ru(CO)₄, Ru(CO)Br, Ru(CO₂)Cl₂, Ru(CO₂)Br₂, Ru(CO)₂I₂, Ru(NO)Br₂, Ru(NO)I₂, H₄[Ru(CN)₆], Na₄[Ru(CN)₆], K₄[Ru(CN)₆], Ca₂[Ru(CN)₆], Sr₂[Ru(CN)₆], Ba₂[Ru(CN)₆], [Ru(phen)₃]Cl₂, [Ru(phen)₃]I₂, [Ru(phen)₃](ClO₄)₂, RuS₂, RuSe₂, RuTe₂, RuCl₃, RuBr₃, RuI₃, Na₃[RuCl₆], K₃[RuCl₆], Na₂[RuCl₅(OH)₂], K₂[RuCl₅(OH)₂], Na₂[RuCl₅(NO)], K₂[RuCl₅(NO)], [Ru(NH₃)₆]Cl₃, [Ru(NH₃)₆]Br₃, [Ru(NH₃)₆]I₃, Ru(acac)₃, RuO₂, Na₂[RuCl₆], K₂[RuCl₆], Na₄[Cl₅RuORuCl₅], RuF₅, H₂RuO₄, (NH₄)₂RuO₄, Na₂RuO₄, K₂RuO₄, NaRuO₄, KRuO₄, RuO₄,. These ruthenium compounds can be also advantageously used in the form of a hydrate in the invention. Among the above ruthenium compounds, RuCl₃, RuBr₃, RuI₃ and RuO₂ are preferred. The rhenium catalyst for use in the invention can be any of conventional rhenium compounds in the form of an oxide, sulfide, halide, complex salts. Typical examples include Re₂O₃, ReCl₃, ReBr₃, Na[ReCl₄], K[ReCl₄], ReO₂, Na₂ReO₃, K₂ReO₃, ReS₂, ReF₄, K₂[ReCl₆], Cs₂[ReCl₆], (NH₄)₂[ReCl₆], NaReO₃, KReO₃, K₂[ReOCl₅], (NH₄)₂[ReOCl₅], ReCl₅, ReO₃, Na₂ReO₄, K₂ReO₄, ReF₆, ReOF₄, ReO₂F₂, ReOCl₄, Re₂O₇, NaR₄O₄, KReO₄, Re₂S₇, NaReO₃S, KReO₃S, ReO₃Cl, ReO₃Br, etc. These rhenium compounds may be used also in the form of a hydrate in the invention. Among the above examples, a preferred rhenium compound is Re₂O₇. The amount of ruthenium or rhenium catalyst used theoretically suffices if it results in the presence of one molecule in the reaction system. A typical amount is in the range of about 0.0001 to about 0.5 mole, preferably about 0.001 to about 0.2 mole, per mole of the compound of the formula (1). Examples of useful periodic acids or salts thereof are orthoperiodic acid, metaperiodic acid, or salts thereof among which metaperiodic acid and a salt thereof are preferred, and metaperiodic acid and an alkali metal salt thereof are more preferred. The amount of the periodic acid or a salt thereof to be used is variable depending on the kind of the compound to be reacted, typically in the range of about 1 to 15 moles, preferably about 1 to 8 moles, per mole of the compound of the formula (1) when the compound of the formula (1) has one alkenyl group as the substituent. Yet the amount is double if the compound of the formula (1) has two alkenyl groups as the substituents. The oxidizing reaction of the invention is carried out in an organic solvent or a water-containing organic solvent or in a two-phase system if the organic solvent used is immiscible with water. Useful organic solvents include a wide range of conventional ones which are capable of dissolving the compound of the formula (1) and which remain inactive under the reaction conditions. Examples of useful organic solvents are methanol, ethanol, propanol, isopropanol, butanol, tert-butanol and like alcohols, methyl formate, ethyl formate, propyl formate, butyl formate, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, methyl propionate, ethyl propionate and like lower alkyl esters of lower carboxylic acids, acetone, methyl ethyl ketone, methyl propyl ketone, methyl butyl ketone, methyl isobutyl ketone, diethyl ketone and like ketones, diethyl ether, ethyl propyl ether, ethyl butyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, methyl cellosolve, dimethoxy ethane and like ethers, tetrahydrofuran, dioxane and like cyclic ethers, acetonitrile, propionitrile, butyronitrile, isobutyronitrile, valeronitrile and like nitriles, benzene, toluene, xylene, chlorobenzene, anisole and like substituted or unsubstituted aromatic hydrocarbons, dichloromethane, chloroform, dichloroethane, trichloroethane, dibromoethane, propylenedichloride, carbon tetrachloride, freons and like halogenated hydrocarbons, pentane, hexane, heptane, octane and like aliphatic hydrocarbons, cyclopentane, cyclohexane, cycloheptane, cyclooctane and like cycloalkanes, dimethylformamide, dimethylacetamide and like amides, dimethylsulfoxides,. These organic solvents can be used singly or at least two of them are usable in mixture. The organic solvent may contain water, when so required. The amount of the organic solvent used is about 0.5 to about 200 ℓ, preferably about 1 to about 50 ℓ, per kilogram of the compound of the formula (1). A suitable oxidizing reaction temperature employable in the invention is variable depending on the kinds of the starting compound, catalyst, solvent and like substances used, typically in the range of about -20 to about 50°C, preferably about -5 to about 30°C. After completion of the reaction, the contemplated β-lactam derivative of the formula (2) and/or the correspondng enol tautomer producible depending on its structure can be obtained by separation from the reaction product, for example, by means of conventional extraction techniques. The obtained desired compound can be purified, when required, by common purification procedures such as recrystallization, column chromatography,. According to the present invention, the β-lactam derivative of the formula (2) and/or the corresponding enol tautomer producible depending on its structure can be easily and safely produced with a high purity in a high yield by means of simple procedure without use of specific apparatus, using easily available equipment and medicinal agent, etc. Examples The present invention will be described below in greater detail with reference to the following examples. Example 1 The above compound (1a) was dissolved in a solvent mixture of 20 ml of acetone and 10 ml of water, and the resulting solution was cooled in an ice bath. To the solution were added 2 g of periodic acid and 2.2 mg of ruthenium dioxide, and the resulting mixture was reacted with stirring for 4 hours. A 50 ml quantity of water was added to the reaction mixture obtained above and the mixture was extracted with 50 ml of ethyl acetate. The organic layer was separated, washed with a mixture of 10 ml of a 5% aqueous solution of hypo, 10 ml of a 5% aqueous solution of sodium hydrogen carbonate and 20 ml of a saturated saline solution and dried over anhydrous magnesium sulfate. The residue thus obtained was concentrated under reduced pressure, giving the desired compound (2a) in a yield of 98%. The NMR spectrum data on this compound were identical with those on an authentic compound (2a) synthesized by another process. Example 2 The above compound (1b) was reacted in the same manner as in Example 1, giving the desired compound (2b) in a yield of 96%. The NMR spectrum data on this compound were identical with those on an authentic compound (2b) synthesized by another process. Example 3 The desired compound (2c) was prepared in a yield of 95% by reacting the above compound (1c) in the same manner as in Example 1. The NMR spectrum data on the compound thus obtained were identical with those on an authentic compound (2c) synthesized by another process. Example 4 The desired compound (2d) was produced in a yield of 90% by reacting the above compound (1d) in the same manner as in Example 1. The NMR spectrum data on the thus obtained compound (2d) were identical with those on an authentic compound (2c) synthesized by another process. Example 5 The above compound (1a) and 200 mg of periodic acid were dissolved in a solvent mixture of 2 ml of tetrahydrofuran and 1 ml of water. A 5 mg quantity of Re₂O₇ was added to the solution obtained above and the mixture was reacted with stirring at room temperature for 21 hours. A 10 ml quantity of water was added to the reaction mixture obtained above and the resulting mixture was extracted with 10 ml of ethyl acetate. The organic layer was separated, washed with a mixture of 1 ml of a 5% aqueous solution of hypo, 1 ml of a 5% aqueous solution of sodium hydrogen carbonate and 5 ml of a saturated saline solution and dried over anhydrous magnesium sulfate. The resulting residue was concentrated under reduced pressure, giving the desired compound (2a) in a yield of 85%. The NMR spectrum data on the thus obtained compound were identical with those obtained with an authentic compound (2a) prepared by another process. Example 6 A 100 mg quantity of the above compound (1e) was dissolved in a solvent mixture of 2 ml of acetone and 1 ml of water. The obtained solution was cooled to 15°C, 200 mg of periodic acid and 1 mg of ruthenium dioxide were added thereto and the resulting mixture was reacted with stirring for 40 minutes. A 10 ml quantity of water was added to the reaction mixture obtained above and the resulting mixture was extracted with 10 ml of ethyl acetate. The organic layer was separated, washed with a mixture of 1 ml of a 5% aqueous solution of hypo, 1 ml of a 5% aqueous solution of sodium hydrogen carbonate and 5 ml of a saturated saline solution and dried over anhydrous magnesium sulfate. The residue obtained was concentrated under reduced pressure, giving the desired compound (2e) in a yield of 92%. NMR spectrum (CDCl₃) δ (ppm): 3.60 (s, 2H), 3.80 (s, 3H), 4.23 (ABq, 2H, J=13.0 Hz), 4.73 (dd, 1H, J=5.0 Hz, 7.0 Hz) 5.12 (ABq, 2H, J=13.0 Hz) 5.71 (d, 1H, J=5.0 Hz), 6.27 (d, 1H, J=7.0 Hz) 6.80 - 8.00 (m, 14H) Example 7 The above compound (1f) was reacted in the same manner as in Example 6, giving the desired compound (2f) in a yield of 92%. NMR spectrum (CDCl₃) δ (ppm): 3.63 (s, 2H), 4.20 (ABq, 2H, J=13.0 Hz) 4.76 (dd, 1H, J=5.0 Hz, 7.0 Hz) 5.72 (d, 1H, J=5.0 Hz), 6.10 (d, 1H, J=7.0 Hz) 6.85 (s, 1H), 7.05 - 7.50 (m, 20H) Example 8 The above compound (1g) was reacted in the same manner as in Example 6, giving the desired compound (2g) in a yield of 90%. NMR spectrum (CDCl₃) δ (ppm): 3.70 (s, 2H), 3.80 (s, 3H) 4.23 (ABq, 2H, J=13.0 Hz) 4.94 (dd, 1H, J=6.0 Hz, 8.0 Hz) 5.15 (ABq, 2H, J=13.0 Hz), 5.78 (d, 1H, J=6.0 Hz) 6.75 - 7.95 (m, 14H) Example 9 A 500 mg quantity of the above compound (1h) was dissolved in 10 ml of acetone and 2.5 ml of water was added thereto. The resulting mixture was cooled in an ice bath, 875 mg of periodic acid and 5 mg of RuCl₃ were added and the resulting mixture was reacted with stirring at 3°C for 4 hours. To the reaction mixture thus obtained were added an aqueous solution of hypo and an aqueous solution of sodium hydrogen carbonate. The resulting mixture was extracted with benzene and the organic layer was separated. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure, giving the desired compound (2h) in a yield of 86%. NMR spectrum (CDCl₃) δ (ppm): 0.05 (s, 3H), 0.10 (s, 3H) 0.75 (s, 9H), 1.55 (d, 3H, J=12.0 Hz) 4.60 (m, 2H) 4.80 (dd, 1H, J=6.0 Hz, 9.0 Hz) 5.13 (ABq, 2H, J=12.0 Hz), 5.65 (d, 1H, J=9.0 Hz) 7.15 - 7.85 (m, 9H) 9.85 (d, 1H, J=6.0 Hz) Example 10 The above compound (1i) was reacted in the same manner as in Example 9, giving the desired compound (2i) in a yield of 85%. NMR spectrum (CDCl₃) δ (ppm): 1.53 (d, 1H, J=8.5 Hz) 4.30 - 4.80 (m, 2H) 5.05 (dd, 1H, J=6.0 Hz, 8.5 Hz) 4.98 (ABq, 2H, J=22 Hz), 5.77 (d, 1H, J=8.5 Hz) 6.90 - 7.90 (m, 24H) 10.00 (d, 1H) Example 11 The above compound (1j) (a mixture of diastereomers in the bonded carbon atom of the ester group for bondage) was reacted in the same manner as in Example 9, giving the desired compound (2j) (diastereomer mixture) in a yield of 94%. NMR spectrum (CDCl₃) δ (ppm): 1.65, 1.39 (ss, 3H) 3.50 - 3.95 (m, 4H) 4.60 - 4.80 (m, 1H) 5.18, 5.23 (ABq, ABq, 1H, J=24 Hz) 5.10 - 5.25 (m, 1H), 5.55, 5.62 (d, d, 1H, J=6.0 Hz) 6.65 - 7.90 (m, 9H) 9.73, 9.81 (d, d, 1H, J=6.0 Hz)

Claims: A process for preparing a β-lactam derivative represented by the following formula (2) and/or the corresponding enol tautomer (which may be produced depending on its structure), the process comprising oxidizing an alkenyl-substituted β-lactam derivative represented by the following formula (1) in an organic solvent or water containing organic solvent or in a two-phase system if the organic solvent used is immiscible with water and in the presence of a ruthenium catalyst or a rhenium catalyst using a periodic acid or a salt thereof: wherein R¹ is a hydrogen atom, a C₁₋₄ alkyl group or a C₁₋₄ haloalkyl group, R² is a hydrogen atom, a C₁₋₄ alkyl group or a phenyl group which may have a substituent, A is a group represented by the formula a group represented by the formula or a group represented by the formula wherein R³ is an amino group or a protected amino group, R⁴ is a hydrogen atom or a group for protecting a carboxylic acid, one of R⁵ and R⁶ is a hydrogen atom and the other is either a hydroxyl group or a protected hydroxyl group, or R⁵ and R⁶, when taken together, represent an oxo group or a group represented by the formula wherein R⁷ is a hydrogen atom, a C₁₋₄ alkyl group, a phenyl group which may have a substituent, or a group -COOR⁸ wherein R⁸ is a hydrogen atom or a C₁₋₄ alkyl group, X is a hydrogen atom, a halogen atom, a hydroxyl group or a protected hydroxyl group, and Y is a group of the formula -SO₂Ar or -SAr wherein Ar is an aryl group which may have a substituent or a nitrogen-containing aromatic heterocyclic group which may have a substituent; wherein R¹ and A are as defined above. A process according to claim 1 wherein the ruthenium catalyst is an oxide, a halide or a complex salt of ruthenium or a hydrate thereof. A process according to claim 1 wherein the rhenium catalyst is an oxide, a halide or a complex salt of rhenium or a hydrate thereof. A process according to any one of claims 1 - 3 wherein the amount of the catalyst used is about 0.0001 to about 0.5 mol, preferably about 0.001 to about 0.2 mole, per mole of the alkenyl-substituted β-lactam derivative. A process according to any one of claims 1 - 4 wherein the periodic acid or a salt thereof is orthoperiodic acid, metaperiodic acid or a salt thereof. A process according to any one of claims 1 - 5 wherein the amount of the periodic acid or a salt thereof used is about 1 to about 15 moles, preferably about 1 to about 8 moles, per mole of the alkenyl-substituted β-lactam derivative which has one alkenyl group as the substituent. A process according to claim 6 wherein the amount of the periodic acid or a salt thereof used when the alkenyl-substituted β-lactam derivative has two alkenyl groups as substituents is double the amount thereof when the alkenyl-substituted β-lactam derivative has one alkenyl group as the substituent.

Inventors: KAMEYAMA YUTAKA, KIKUCHI RYO, SASAOKA MICHIO, SHIROI TAKASHI, TANAKA HIDEO, TANIGUCHI MASATOSHI, TORII SIGERU, KAMEYAMA, YUTAKA, KIKUCHI, RYO, SASAOKA, MICHIO, SHIROI, TAKASHI, TANAKA, HIDEO, TANIGUCHI, MASATOSHI, TORII, SIGERU
Applicants: OTSUKA KAGAKU KK, OTSUKA KAGAKU KABUSHIKI KAISHA
Application year: 1991
Main classification: C07D205
IPC codes: C07F7, C07B61, C07D205, C07D405, C07D403, B01J23, C01B11